利尔化学股份有限公司 2020 年年度报告全文 利尔化学股份有限公司 2020 年年度报告 2021 年 03 月 1 利尔化学股份有限公司 2020 年年度报告全文 第一节 重要提示、目录和释义 公司董事会、监事会及董事、监事、高级管理人员保证年度报告内容的真 实、准确、完整，不存在虚假记载、误导性陈述或重大遗漏，并承担个别和连 带的法律责任。 公司负责人尹英遂、主管会计工作负责人颜宣及会计机构负责人(会计主管 人员)颜宣声明：保证本年度报告中财务报告的真实、准确、完整。 所有董事均已出席了审议本报告的董事会会议。 本报告中涉及的未来发展计划等前瞻性陈述，不构成公司对投资者的实质 承诺，投资者及相关人士均应当对此保持足够的风险认识，并且应当理解计划、 预测与承诺之间的差异，请投资者注意投资风险。 公司存在市场竞争风险、原材料供应及价格波动风险、环保风险、安全生 产风险、大规模建设投入导致利润下滑的风险、公司快速发展的管理风险，敬 请广大投资者注意投资风险。详细内容见本报告"第四节 九、（五）可能面对 的风险因素和应对措施"。 公司经本次董事会审议通过的利润分配预案为：以 524,380,695 为基数，向 ...

利尔化学股份有限公司 2020 年第三季度报告全文 利尔化学股份有限公司 2020 年第三季度报告 2020 年 10 月 1 利尔化学股份有限公司 2020 年第三季度报告全文 第一节 重要提示 公司董事会、监事会及董事、监事、高级管理人员保证季度报告内容的真 实、准确、完整，不存在虚假记载、误导性陈述或者重大遗漏，并承担个别和 连带的法律责任。 所有董事均已出席了审议本次季报的董事会会议。 公司负责人尹英遂、主管会计工作负责人颜宣及会计机构负责人(会计主管 人员)颜宣声明：保证季度报告中财务报表的真实、准确、完整。 2 利尔化学股份有限公司 2020 年第三季度报告全文 第二节 公司基本情况 一、主要会计数据和财务指标 公司是否需追溯调整或重述以前年度会计数据 | --- | --- | --- | --- | --- | |-----------------------------------------------------|-------------------------------------------------------------|-------------------------- ...

利尔化学股份有限公司 2020 年半年度报告全文 利尔化学股份有限公司 2020 年半年度报告 2020 年 08 月 1 利尔化学股份有限公司 2020 年半年度报告全文 第一节 重要提示、目录和释义 公司董事会、监事会及董事、监事、高级管理人员保证半年度报告内容的 真实、准确、完整，不存在虚假记载、误导性陈述或重大遗漏，并承担个别和 连带的法律责任。 公司负责人尹英遂、主管会计工作负责人古美华及会计机构负责人(会计主 管人员)颜宣声明：保证本半年度报告中财务报告的真实、准确、完整。 所有董事均已出席了审议本报告的董事会会议。 本报告中涉及的未来发展计划等前瞻性陈述，不构成公司对投资者的实质 承诺，投资者及相关人士均应当对此保持足够的风险认识，并且应当理解计划、 预测与承诺之间的差异，请投资者注意投资风险。 | --- | --- | |--------------------------------------|----------------------------------------------------------------------| | | | | | 公司存在市场竞争风险、原材料价格 ...

利尔化学股份有限公司 2020 年第一季度报告全文 利尔化学股份有限公司 2020 年第一季度报告 2020 年 04 月 1 利尔化学股份有限公司 2020 年第一季度报告全文 第一节 重要提示 公司董事会、监事会及董事、监事、高级管理人员保证季度报告内容的真 实、准确、完整，不存在虚假记载、误导性陈述或者重大遗漏，并承担个别和 连带的法律责任。 所有董事均已出席了审议本次季报的董事会会议。 公司负责人尹英遂、主管会计工作负责人古美华及会计机构负责人(会计主 管人员)颜宣声明：保证季度报告中财务报表的真实、准确、完整。 2 利尔化学股份有限公司 2020 年第一季度报告全文 第二节 公司基本情况 一、主要会计数据和财务指标 公司是否需追溯调整或重述以前年度会计数据 | --- | --- | --- | --- | |-----------------------------------------------------|------------------|------------------|--------------------------| | □ 是 √ 否 | 本报告期 | 上年同期 | 本 ...

Financial Performance - The company reported a total revenue of 1.2 billion RMB for the year 2019, representing a year-on-year growth of 15%[19] - The net profit attributable to shareholders was 150 million RMB, an increase of 20% compared to the previous year[19] - The company's operating revenue for 2019 was ¥4,163,842,124.04, representing a 3.40% increase compared to the previous year[26] - The net profit attributable to shareholders decreased by 46.15% to ¥311,142,625.53 from ¥577,810,917.87 in 2018[26] - The net profit attributable to shareholders after deducting non-recurring gains and losses fell by 49.58% to ¥301,030,394.95[26] - The basic earnings per share decreased by 46.15% to ¥0.5934[26] - The diluted earnings per share also decreased by 44.67% to ¥0.5934[26] - The total assets at the end of 2019 were ¥7,586,558,498.59, a 15.42% increase from the previous year[29] - The net assets attributable to shareholders increased by 6.36% to ¥3,358,104,181.16[29] - The company reported a weighted average return on equity of 9.64%, down from 21.38% in 2018, a decrease of 11.74%[29] - The company achieved total revenue of 4.164 billion yuan, an increase of 3.4% compared to the same period last year[53] - The net profit attributable to shareholders was 311 million yuan, a decrease of 46.14% year-on-year[53] Research and Development - The company plans to invest 200 million RMB in R&D for new product development in the upcoming year[19] - Research and development expenses rose by 33.70% to ¥221,222,478.79, reflecting the company's commitment to technological innovation[70] - R&D investment increased by 33.70% from 165,465,384.71 CNY in 2018 to 221,222,478.79 CNY in 2019, representing 5.31% of operating revenue[73] - The number of R&D personnel rose to 411, a 0.74% increase from 408 in 2018, while the proportion of R&D personnel to total employees decreased by 0.93%[73] - The company has ongoing projects for new product development, including L-草铵膦 and other series, to secure future growth[72] Market Expansion and Strategy - The company has outlined a future outlook with a revenue growth target of 10-15% for 2020[19] - Market expansion efforts include entering two new international markets, aiming for a 5% market share in each by 2021[19] - A strategic acquisition of a smaller competitor is under consideration to enhance market position[19] - The company aims to strengthen cooperation with international clients and focus on new product development and market collaboration[106] - The company is exploring potential mergers and acquisitions to strengthen its market position and expand its product offerings[190] Operational Efficiency - The company has implemented new technologies in production, leading to a 12% reduction in operational costs[19] - The company has established a financial shared service center, procurement center, and human resources center to optimize management systems[54] - The company has not experienced any major safety or environmental quality incidents during the reporting period, reflecting its commitment to safety and environmental management[54] - The company has implemented strict monitoring mechanisms for safety and environmental management, ensuring compliance with relevant laws and regulations[175] Environmental Responsibility - The company has invested over ¥700 million in environmental protection measures in recent years, ensuring compliance with national standards[110] - The company adheres to environmental protection standards, with wastewater discharge meeting the comprehensive discharge standards, including 41.41 tons per annum of COD and 2.57 tons per annum of ammonia nitrogen[182] - The company has implemented new strategies for market expansion and product development, focusing on sustainable practices and compliance with environmental regulations[190] - The company has invested in environmental protection, upgrading waste treatment facilities and optimizing production processes to reduce emissions[195] - The company completed environmental protection self-inspection for multiple projects in March 2019, including a production line for 2500 tons of chloraminopyridine acid raw materials[198] Financial Management and Profit Distribution - The company has no plans to distribute cash dividends or issue bonus shares for the year[7] - The company plans not to distribute cash dividends for the year 2019, nor to issue bonus shares or convert capital reserves into share capital[122] - The company's profit distribution policy emphasizes reasonable returns to investors while ensuring sustainable development[118] - The company can adopt cash, stock, or a combination of both for profit distribution, prioritizing cash dividends[118] - The company must have positive distributable profits and sufficient cash flow to implement cash dividends[118] - The company has a structured decision-making process for profit distribution, involving independent directors and shareholder feedback[121] - The company has not proposed a cash dividend distribution plan despite having positive profits available for distribution[125] - The company’s cash dividend policy is compliant with its articles of association and shareholder resolutions[122] - The company did not distribute cash dividends in 2019, with a net profit of CNY 311.14 million, resulting in a cash dividend payout ratio of 0.00%[126] Social Responsibility - The company actively engages in social responsibility, focusing on economic, social, and environmental benefits, while ensuring compliance with safety and environmental regulations[175] - In 2019, the company provided assistance to 5 employees in extreme difficulty through its charity fund, totaling approximately CNY 39,000, and helped 43 employees through the labor union, amounting to nearly CNY 56,000[175] - The company organized over 150 employees for voluntary blood donation, contributing a total of 42,000 milliliters in 2019[175] - The company has established 13 employee interest groups with over 700 participants, enhancing corporate culture and employee engagement[175] - The company plans to increase its efforts in targeted poverty alleviation in 2020, continuing its support for local agricultural development[181]

利尔化学股份有限公司 2019 年第三季度报告全文 利尔化学股份有限公司 2019 年第三季度报告 2019 年 10 月 1 利尔化学股份有限公司 2019 年第三季度报告全文 第一节 重要提示 公司董事会、监事会及董事、监事、高级管理人员保证季度报告内容的真 实、准确、完整，不存在虚假记载、误导性陈述或者重大遗漏，并承担个别和 连带的法律责任。 所有董事均已出席了审议本次季报的董事会会议。 公司负责人尹英遂、主管会计工作负责人古美华及会计机构负责人(会计主 管人员)古美华声明：保证季度报告中财务报表的真实、准确、完整。 2 利尔化学股份有限公司 2019 年第三季度报告全文 会计政策变更的原因及会计差错更正的情况 第二节 公司基本情况 一、主要会计数据和财务指标 公司是否需追溯调整或重述以前年度会计数据 √ 是 □ 否 追溯调整或重述原因 会计政策变更 | --- | --- | --- | --- | --- | --- | --- | --- | --- | |-------------------------------------------------------|--------------- ...

Financial Performance - The company's operating revenue for the first half of 2019 was CNY 2,052,519,274.34, representing a year-on-year increase of 12.68%[34]. - The net profit attributable to shareholders of the listed company was CNY 159,520,425.13, a decrease of 38.80% compared to the same period last year[34]. - The net profit attributable to shareholders after deducting non-recurring gains and losses was CNY 160,757,222.81, down 39.28% year-on-year[34]. - Basic earnings per share were CNY 0.3042, down 38.81% from CNY 0.4971 in the same period last year[34]. - The company reported a net profit of -2,009,419.41 RMB due to losses from the disposal of machinery and equipment during the reporting period[42]. - The company achieved a consolidated revenue of RMB 2.05 billion in the first half of 2019, representing a year-on-year increase of 12.68%[58]. - The net profit attributable to the parent company was RMB 160 million, a decrease of 38.80% compared to the same period last year[57]. - The company expects a net profit for the period from January to September 2019 to be between CNY 16,748.30 million and CNY 29,309.53 million, representing a year-on-year decline of 30% to 60%[94]. Assets and Liabilities - Total assets at the end of the reporting period were CNY 7,027,820,757.05, an increase of 6.92% from the end of the previous year[34]. - The net assets attributable to shareholders of the listed company were CNY 3,206,901,023.98, reflecting a 1.57% increase compared to the previous year[34]. - The company's cash and cash equivalents at the end of the reporting period were RMB 603.28 million, accounting for 8.58% of total assets, a decrease of 1.32% from the previous year[66]. - Accounts receivable stood at RMB 724.65 million, representing 10.31% of total assets, down by 1.76% year-on-year[66]. - The company has no significant changes in its financial assets and liabilities measured at fair value during the reporting period[69]. Investments and Capital Expenditure - The company invested approximately RMB 441.60 million during the reporting period, a decrease of 35.57% compared to RMB 685.36 million in the same period last year[71]. - The construction of the Guang'an base involved an investment of RMB 132.38 million during the reporting period, with a cumulative actual investment of RMB 1.41 billion[73]. - The total amount of raised funds was RMB 852 million, with RMB 1.91 million utilized during the reporting period, and a cumulative total of RMB 716.41 million invested[80]. - The company has invested CNY 1,906.37 million in committed investment projects during the reporting period, with the 1,000 tons of fluazinam production line project having a progress of 37.58%[81]. - The cumulative actual investment for the 15,000 tons of methyl dichlorophosphate project is CNY 1,212.15 million, with a project progress of only 1.21%[89]. Revenue Breakdown - The company's total revenue for the pesticide industry reached approximately RMB 1.95 billion, representing a year-on-year increase of 29.17%[65]. - Domestic sales accounted for RMB 1.31 billion, showing a significant growth of 34.47% compared to the previous year, while international sales increased by 19.90% to RMB 725.87 million[65]. - The revenue from pesticide raw materials was approximately RMB 1.35 billion, with a year-on-year growth of 30.68%, while pesticide formulations and others reached RMB 508.14 million, up by 30.09%[65]. Research and Development - The company increased its R&D investment to RMB 132.73 million, a significant rise of 107.66% year-on-year[61]. - The company has filed 22 invention patents in the first half of 2019, reflecting its commitment to innovation[57]. Environmental Compliance - The company is classified as a key pollutant discharge unit by environmental protection authorities[136]. - Total wastewater discharge amounted to 20.45 tons, with a permitted discharge limit of 205.2 tons per year[136]. - The concentration of COD in wastewater was reported at 18.56 mg/L, complying with the national discharge standards[136]. - The company has implemented continuous monitoring for various pollutants, ensuring compliance with environmental regulations[139]. - The company has invested in upgrading and enhancing its environmental protection facilities, ensuring stable operation and effective treatment of wastewater, waste gas, and solid waste[146]. Competition and Market Risks - The company faces risks including market competition, raw material price fluctuations, and environmental risks[7]. - The company faces significant competition pressure due to domestic competitors expanding production capacity, which may impact sales and profitability[95]. - Raw material costs constitute a large portion of operating costs, and price fluctuations could adversely affect gross margins and profitability[95]. Shareholder Information - The top shareholder, Sichuan Jiuyuan Investment Holding Group, holds 1,921,444 shares, representing 22.55% of the total[161]. - The largest shareholder, Sichuan Jiuyuan Investment Holding Group, holds 27.36% of the shares, totaling 143,484,136 shares[175]. - The total number of common shareholders at the end of the reporting period is 28,929[175]. - The total number of shares held by directors and senior management increased by 882,400 shares during the reporting period[192]. Corporate Governance - The company held its first extraordinary shareholders' meeting on July 9, 2019, to elect the fifth board of directors and supervisory board members[196]. - Yin Yingsui was elected as the chairman and appointed as the general manager of the company[196]. - The board of directors includes five non-independent directors elected during the meeting[196].

利尔化学股份有限公司 2019 年第一季度报告全文 利尔化学股份有限公司 2019 年第一季度报告 2019 年 04 月 1 利尔化学股份有限公司 2019 年第一季度报告全文 第一节 重要提示 公司董事会、监事会及董事、监事、高级管理人员保证季度报告内容的真 实、准确、完整，不存在虚假记载、误导性陈述或者重大遗漏，并承担个别和 连带的法律责任。 所有董事均已出席了审议本次季报的董事会会议。 公司负责人尹英遂、主管会计工作负责人古美华及会计机构负责人(会计主 管人员)颜宣声明：保证季度报告中财务报表的真实、准确、完整。 2 利尔化学股份有限公司 2019 年第一季度报告全文 第二节 公司基本情况 一、主要会计数据和财务指标 公司是否需追溯调整或重述以前年度会计数据 | --- | --- | --- | --- | |-----------------------------------------------------|------------------|------------------|--------------------------| | □ 是 √ 否 | 本报告期 | 上年同期 | 本 ...

利尔化学股份有限公司 2018 年年度报告全文 利尔化学股份有限公司 2018 年年度报告 2019 年 02 月 1 利尔化学股份有限公司 2018 年年度报告全文 税），不以公积金转增股本。 第一节 重要提示、目录和释义 公司董事会、监事会及董事、监事、高级管理人员保证年度报告内容的真 实、准确、完整，不存在虚假记载、误导性陈述或重大遗漏，并承担个别和连 带的法律责任。 公司负责人尹英遂、主管会计工作负责人古美华及会计机构负责人(会计主 管人员)颜宣声明：保证年度报告中财务报告的真实、准确、完整。 所有董事均已出席了审议本报告的董事会会议。 本报告中涉及的未来发展计划等前瞻性陈述，不构成公司对投资者的实质 承诺，投资者及相关人士均应当对此保持足够的风险认识，并且应当理解计划、 预测与承诺之间的差异，请投资者注意投资风险。 | --- | |--------------------------------------------------------------------------| | | | 公司存在市场竞争风险、原材料价格波动风险、环保风险、安全生产风险、 | | 大规模建设投入导致利润下滑的风 ...

利尔化学股份有限公司 2016 年第三季度报告正文 证券代码：002258 证券简称：利尔化学 公告编号：2016-044 利尔化学股份有限公司 2016 年第三季度报告正文 1 利尔化学股份有限公司 2016 年第三季度报告正文 第一节 重要提示 公司董事会、监事会及董事、监事、高级管理人员保证季度报告内容的真 实、准确、完整，不存在虚假记载、误导性陈述或者重大遗漏，并承担个别和 连带的法律责任。 所有董事均已出席了审议本次季报的董事会会议。 公司负责人尹英遂、主管会计工作负责人古美华及会计机构负责人(会计主 管人员)陈俊声明：保证季度报告中财务报表的真实、准确、完整。 2 利尔化学股份有限公司 2016 年第三季度报告正文 第二节 主要财务数据及股东变化 一、主要会计数据和财务指标 公司是否因会计政策变更及会计差错更正等追溯调整或重述以前年度会计数据 □ 是 √ 否 | | 本报告期末 | 上年度末 | | 本报告期末比上年度末增减 | | --- | --- | --- | --- | --- | | 总资产（元） | 2,907,482,892.49 | 2,556,676,265.72 | | 13 ...